FDA Approves First New Weight-Loss Drug in More Than a Decade
Belviq targeted for adults with health problems such as high blood pressure, type 2 diabetesContinue Reading
Belviq targeted for adults with health problems such as high blood pressure, type 2 diabetesContinue Reading
Overweight men more likely than normal-weight men to have low levels of the hormone, study saysContinue Reading
About half of patients with type 2 diabetes were resistant to the pill’s effects, study foundContinue Reading
Findings also suggest an association with obesity, but more research is neededContinue Reading
The standby drug had a lower death risk than 3 different meds from the sulfonylurea groupContinue Reading
For some, bariatric procedures banish the disease, but only for a whileContinue Reading
Obese patients who had bariatric procedure had lower rates of kidney disease, study foundContinue Reading
Black women lost less than whites, but the gap was narrower when diabetes was present, study findsContinue Reading
More are exercising and not smoking, but obesity, diabetes rates still increasingContinue Reading
Findings suggest chronic kidney disease could help ID people at risk for heart diseaseContinue Reading
Obesity may be the key to both, experts sayContinue Reading
Older adults with poor blood sugar control performed worse on tests of memory, thinkingContinue Reading
Sleeping disorder seems to play role in diabetic peripheral neuropathy; more research neededContinue Reading
Researchers urge primary care doctors to screen those with type 2 disease for the disorderContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.